Bio-Plexus completes $2.5 million financing:
This article was originally published in Clinica
Safety needle company Bio-Plexus has closed a $2.5m round of new debt financing. The Vernon, Connecticut company plans to use the financing to further the launch of its Winged set product line. Investment bank Commonwealth Associates, which acted as the sole advisor and agent on the transaction, evaluates the market potential for Bio-Plexus' safety needle products at around $350m.